Labcorp Credit Rating & NNN Cap Rate

Company	Labcorp
Parent	Laboratory Corporation of America Holdings
Ticker	LH
Exchange	NYSE
Sector	Healthcare Services
S&P Rating	BB+
Moody’s Rating	Ba1
Investment Grade	No
US Locations	2,000+
Revenue	$3.2B
Cap Rate Range	5.00% – 6.00%
Lease Term	10 years
Building Sq Ft	3,000 – 50,000

Business Overview

Laboratory Corporation of America, known as Labcorp, operates as one of the largest clinical laboratory networks in the United States. With over 2,000 patient service centers across the country, Labcorp provides comprehensive diagnostic testing, drug development services, and clinical laboratory testing capabilities to healthcare providers, patients, and pharmaceutical companies.

Labcorp’s extensive real estate footprint consists primarily of patient service centers, reference laboratories, and specialized testing facilities. These properties range from small walk-in centers in retail environments to large reference laboratories processing millions of test samples annually. For triple-net lease investors, Labcorp represents exposure to the resilient healthcare diagnostic sector with recurring revenue from routine testing and specialized services.

Explore more information at InvestmentGrade.com, or check out our comprehensive NNN lease resources for additional healthcare operator analysis.

Credit Rating & Investment Grade Status

Investment Grade Designation: No

Labcorp holds a BB+ rating from S&P and Ba1 from Moody’s, placing it in the speculative-grade category. While the BB+ rating is at the higher end of the sub-investment-grade spectrum, it still represents elevated credit risk compared to investment-grade operators. For comprehensive information on rating criteria, refer to our investment-grade credit ratings guide.

Lease Structure & Terms

Labcorp typically negotiates 10-year triple-net lease terms with annual rent escalations of 2–3% and multiple 5-year renewal options. As a NNN tenant, Labcorp assumes responsibility for property taxes, insurance, and common area maintenance expenses across its portfolio.

Patient service centers often include modest tenant improvements for HIPAA compliance, specialized plumbing for specimen handling, electrical upgrades for laboratory equipment, and security systems. Lease agreements may include provisions for equipment removals at lease termination.

Cap Rate & Pricing Expectations

Labcorp properties typically trade at 5.00% – 6.00% cap rates, reflecting its BB+/Ba1 speculative-grade credit status and the resilient healthcare diagnostic sector. The relatively tight range compared to lower-rated logistics or industrial tenants reflects Labcorp’s essential healthcare mission and stable testing volume.

Pricing varies based on property location, patient service center density in the region, remaining lease term, and local market cap rate trends. Properties in densely populated areas with strong demographic demand for medical testing tend toward lower cap rates.

Learn more about cap rate fundamentals in our investment grade guide.

Real Estate Footprint

Labcorp operates 2,000+ patient service centers nationally, with concentrations in metropolitan areas and suburban markets where population density supports routine testing demand. Major markets include California, Texas, Florida, New York, and the Mid-Atlantic region.

Patient service center properties typically feature 3,000–8,000 square feet with features including HIPAA-compliant layouts, secure specimen storage, phlebotomy stations, and privacy-partitioned collection areas. Reference laboratories supporting these centers are significantly larger, often 25,000–50,000+ square feet, with specialized HVAC, controlled environments, and automated specimen handling systems.

Growth Strategy & Market Position

Labcorp pursues strategic expansion of its patient service center network in underserved suburban and rural markets. The company seeks to increase drug development services and specialty testing capabilities. Real estate growth focuses on convenient locations driving patient volume while consolidating redundant facilities to optimize network efficiency.

Pros & Cons for NNN Investors

Pros	Cons
Essential healthcare services with consistent demand Diversified revenue from routine and specialty testing Extensive national footprint reduces concentration risk Recurring revenue model provides lease payment stability	Sub-investment-grade credit rating indicates higher risk Regulatory changes in healthcare reimbursement affect margins Competition from other diagnostic providers and hospitals Telehealth and home testing services reduce facility utilization

Comparable Tenants

Comparable Company	Credit Rating	Sector
Quest Diagnostics	BB+ / Ba2	Healthcare Services
LabOne Inc.	BB– / Ba3	Healthcare Services
AmeriPath (Advance Medical Optics)	BB / Ba2	Healthcare Services
Sonic Healthcare Limited	BBB– / Baa3	Healthcare Services

Frequently Asked Questions

Why does Labcorp hold a sub-investment-grade credit rating despite strong healthcare demand?

While Labcorp operates in a resilient sector, its BB+/Ba1 rating reflects debt levels from acquisitions, competitive reimbursement pressures, and integration challenges. The company’s debt levels exceed what rating agencies consider investment-grade, despite consistent operational cash flow. This is common among healthcare operators managing legacy debt from past acquisitions.

What property types does Labcorp operate for triple-net leases?

Labcorp operates two primary property types: patient service centers (3,000–8,000 sq ft in retail or medical office settings) and reference laboratories (25,000–50,000+ sq ft industrial/medical facilities). Patient service centers dominate the leased real estate portfolio, while many reference laboratories are owned rather than leased.

How does Labcorp’s 2,000+ location strategy affect NNN lease risk?

The extensive national footprint provides significant portfolio diversification, reducing risk from any single property or region. However, it also exposes investors to national healthcare policy changes and reimbursement rate adjustments. The number of locations allows Labcorp flexibility to close underperforming centers, potentially impacting some lease continuity.

What trends could affect Labcorp NNN property values?

Emerging threats include telehealth expansion reducing center visits, home testing kits lowering lab utilization, and regulatory changes affecting Medicare/Medicaid reimbursement rates. Conversely, aging populations increase diagnostic testing demand. Cap rate trends will reflect investor sentiment toward these competing dynamics.

Discover healthcare diagnostic investment opportunities

InvestmentGrade.com specializes in identifying triple-net lease properties with healthcare tenants offering superior cap rates and portfolio diversification. Connect with our team to explore Labcorp and other diagnostic service operators in your target markets.

Bonus Depreciation Advantage
Medical NNN properties deliver meaningful cost segregation value through specialized buildout components. Dialysis systems, dental operatory equipment, imaging infrastructure, laboratory casework, and medical-grade HVAC can be reclassified from 39-year to 5, 7, and 15-year recovery periods, typically representing 30% to 50% of the purchase price. See our full analysis: Medical NNN Bonus Depreciation: Dialysis, Dental, and Urgent Care Properties.

The Only Labcorp NNN Advisor Whose Fee Comes From the Deal, Not From You

In NNN buyer representation, the listing broker pays the cooperating commission. That means you get a dedicated Labcorp NNN advisor handling sourcing, underwriting, financing, and closing — and on the majority of transactions, there is no separate fee to you as the buyer.

Here’s what that buys you:

Find It — On-market and off-market Labcorp NNN properties sourced and underwritten on your behalf. We know which markets are pricing correctly, which listings are overpriced for what the lease actually says, and where the spread is worth the move.

Fund It — Acquisition financing through 150+ lender relationships: life companies, CMBS, regional banks, and credit unions that know Labcorp-grade paper. Not the first approval that comes back. The best terms on the table for this specific credit and lease structure.

Exit It — Selling a Labcorp asset or repositioning through a 1031? Our Capital Markets desk runs a quiet, targeted process. Private investors, family offices, and institutional buyers who are actively acquiring Labcorp net lease — not a public blast that signals desperation to the market.

Not committed to Labcorp? Tell us your criteria — cap rate floor, credit tier, lease structure, geography, equity check size — and we’ll find the deal that fits. We represent investors across the full NNN credit spectrum, from QSR and pharmacy to industrial, medical, and big box retail. The tenant is a variable. Your criteria is the constant.

Get Your Free Labcorp NNN Consultation →

In a 1031 exchange with a deadline? Tell us your timeline — we move faster.